Emmanouil Saloustros

Associate Professor

Panepistemio Thessalias Tmema Iatrikes

Greece

Research Interests

Explore related searches

Professors in Medical Science

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Emmanouil Saloustros is an Associate Professor at the Panepistemio Thessalias Tmema Iatrikes in Greece. His research primarily focuses on cancer care, particularly in relation to LGBTQ health, racial and ethnic disparities in clinical trials, and the genetic factors influencing breast cancer susceptibility. He has published extensively on topics such as germline variants in breast cancer cases, genetic testing practices, and real-world data on immunotherapy outcomes in patients with concurrent autoimmune diseases.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (27)

Francine Durocher

Professeure titulaire

Laval University

CANADA

Emmanouil Saloustros

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

An assessment of the attitudes, knowledge, and education regarding the health care needs of LGBTQ patients with cancer: results of an ESMO/SIOPE global survey

Racial and Ethnic Disparities in European Breast Cancer Clinical Trials

Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group

Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes

Physicians’ experience, practice and education, on genetic testing and genetic counseling: a nationwide survey study in Greece

Rare germline copy number variants (CNVs) and breast cancer risk

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

Collaborators (27)

Francine Durocher

Kathleen Claes

William Newman

Marco Montagna

Anna Jakubowska

Angeliki Bania

Alicja Ogrodniczak

Sara Margolin

Heiko Becher

ATOCHA ROMERO

Paolo Radice

Taru Muranen

Logan Walker

Anna Gonzalez-Neira

Stig E. Bojesen

Robert Winqvist

Peter Hillemanns

Nick Orr

Pascal Guenel

Mary Beth Terry

Peter Devilee

Sabine Behrens

mikael eriksson

Håkan Olsson

Marike Gabrielson

Felix Grassmann

Natalia Bogdanova

Make your next move.